EU policies must not push essential medicines off market: new Medicines for Europe president

9 February 2026

President Steffen Saltofte argues that EU policy must protect timely […]

‘Access Is A Right, Not A Privilege’ – Medicines For Europe’s Saltofte Sets Out Priorities

9 February 2026

The president of Medicines for Europe, Steffen Saltofte, says Medicines […]

Overview of the pilots in Europe testing the use of the electronic product information (ePI) for medicines

9 February 2026

Parliament makes the Critical Medicines Act meaningful but significant risks to future access persist

20 January 2026

Steffen Saltofte (Zentiva) named President of Medicines for Europe

7 January 2026

The EU Biosimilar industry, which is central to competitiveness, needs Ambitious, Coherent, & Competition-Driven Biotech Policies

17 December 2025

Parliament SANT Committee vote takes the high road on medicines security in Critical Medicines Act Report

17 December 2025

The Safe Hearts Plan should improve access to affordable innovation and better treatment for all patients

17 December 2025

Pharma legislation deal important for the future EU pharmaceutical industry but most importantly for access to medicine

12 December 2025

Environment omnibus and impact study fail to address huge flaws in Urban waste water treatment directive

12 December 2025